Taken up Covishield travel issue at highest levels: Adar Poonawalla

Reports suggest India plans to take this matter of non-inclusion of Covishield in the list of approved vaccines for European Union (EU) 'Green Pass' up with the EU

Amid reports that people who have taken the Serum Institute of India (SII)-manufactured AstraZeneca vaccine Covishield will face challenges in travelling to Europe, SII CEO Adar Poonawalla said on Monday that he has taken it up at the ‘highest levels’.

In a tweet from his official handle, Poonawalla said, “I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries.”

He says that